Advanced Enzyme Technologies Ltd.
•₹ 300-0.99%
2026-08-21
PROS
- Company is almost debt free
- Company has a healthy return on capital (ROCE) of 22.6%
- Company has been maintaining a healthy dividend payout of 45.4%
- Stock looks reasonably valued - P/E of 21.7 is below its historical median
- Company generates healthy free cash flow
- Company has a consistent dividend-paying track record
CONS
- Recent results are weak - TTM profit is down 56.8% versus prior year
- A large part of profit comes from other income (40.8% of PBT)
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.60x)
- Recurring exceptional / one-off items are inflating headline profit
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1901.00 | 37.71 | 456113.58 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8587.00 | 77.93 | 227957.87 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 4994.90 | 87.11 | 189989.94 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1437.65 | 34.46 | 116141.01 | 0.90 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1108.80 | 24.51 | 110603.22 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2203.10 | 18.22 | 100733.42 | 0.82 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | DRREDDY | 1181.35 | 30.60 | 98604.43 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 8. | MANKIND | 2385.00 | 48.22 | 98499.54 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 9. | LAURUSLABS | 1823.00 | 90.09 | 98498.92 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1606.40 | 24.90 | 92428.71 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 412.10 | 135.59 | 67159.70 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | ADVENZYMES | 303.50 | 20.49 | 3398.48 | 1.76 | 38.59 | -4.58 | 189.79 | 2.09 | 15.27 | 26.85 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85 | 97 | 91 | 92 | 86 | 77 | 101 | 87 | 125 | 116 | 96 | 116 | 116 | |
| 61 | 70 | 67 | 63 | 65 | 64 | 79 | 73 | 94 | 86 | 72 | 90 | 88 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 51 | 1 | 4 | 3 | 54 | 2 | 1 | 5 | 54 | 3 | 1 | 5 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| 73 | 25 | 25 | 10 | 72 | 12 | 21 | 16 | 81 | 30 | 18 | 29 | 30 | |
| Tax % | 8.17% | 25.77% | 24.61% | 69.78% | 7.07% | 25.97% | 26.10% | 28.76% | 9.12% | 24.78% | 25.65% | 22.71% | 24.86% |
| Net Profit | 67 | 18 | 19 | 3 | 67 | 9 | 15 | 11 | 74 | 22 | 13 | 22 | 22 |
| 6 | 2 | 2 | 0 | 6 | 1 | 1 | 1 | 7 | 2 | 1 | 2 | 0 | |
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 85
- 61
- Operating Profit
- —
- OPM %
- —
- Other Income
- 51
- Interest
- 0
- Depreciation
- 3
- 73
- Tax %
- 8.17%
- Net Profit
- 67
- 6
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 97
- 70
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 3
- 25
- Tax %
- 25.77%
- Net Profit
- 18
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 91
- 67
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 0
- Depreciation
- 3
- 25
- Tax %
- 24.61%
- Net Profit
- 19
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 92
- 63
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 0
- Depreciation
- 3
- 10
- Tax %
- 69.78%
- Net Profit
- 3
- 0
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 86
- 65
- Operating Profit
- —
- OPM %
- —
- Other Income
- 54
- Interest
- 0
- Depreciation
- 3
- 72
- Tax %
- 7.07%
- Net Profit
- 67
- 6
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 77
- 64
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 0
- Depreciation
- 3
- 12
- Tax %
- 25.97%
- Net Profit
- 9
- 1
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 101
- 79
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 3
- 21
- Tax %
- 26.10%
- Net Profit
- 15
- 1
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 87
- 73
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 0
- Depreciation
- 3
- 16
- Tax %
- 28.76%
- Net Profit
- 11
- 1
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 125
- 94
- Operating Profit
- —
- OPM %
- —
- Other Income
- 54
- Interest
- 0
- Depreciation
- 3
- 81
- Tax %
- 9.12%
- Net Profit
- 74
- 7
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 116
- 86
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 0
- Depreciation
- 3
- 30
- Tax %
- 24.78%
- Net Profit
- 22
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 96
- 72
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 3
- 18
- Tax %
- 25.65%
- Net Profit
- 13
- 1
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 116
- 90
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 0
- Depreciation
- 3
- 29
- Tax %
- 22.71%
- Net Profit
- 22
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 116
- 88
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 0
- Depreciation
- 3
- 30
- Tax %
- 24.86%
- Net Profit
- 22
- 0
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 173 | 212 | 222 | 247 | 283 | 273 | 312 | 365 | 351 | 453 | 444 | |
| 124 | 163 | 169 | 170 | 183 | 200 | 236 | 260 | 280 | 343 | 336 | |
| Operating Profit | 55 | 55 | 58 | 86 | 108 | 82 | 85 | 164 | 132 | 174 | — |
| OPM % | 32 | 26 | 26 | 35 | 38 | 30 | 27 | 45 | 38 | 38 | — |
| Other Income | 6 | 6 | 6 | 9 | 7 | 9 | 10 | 59 | 61 | 64 | 12 |
| Interest | 3 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Depreciation | 8 | 8 | 9 | 9 | 9 | 10 | 10 | 11 | 11 | 12 | 12 |
| 44 | 44 | 47 | 76 | 98 | 72 | 74 | 134 | 121 | 158 | 106 | |
| Tax % | 21 | 18 | 25 | 24 | 28 | 24 | 25 | 19 | 15 | 16 | 24 |
| Net Profit | 35 | 36 | 35 | 58 | 71 | 55 | 56 | 108 | 102 | 132 | 80 |
| EPS | 3 | 3 | 3 | 5 | 6 | 5 | 5 | 10 | 9 | 12 | — |
| Dividend Payout % | 13 | 16 | 19 | 12 | 14 | 21 | 20 | 53 | 57 | 45 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 3 | 3 | 5 | 6 | 5 | 5 | 10 | 9 | 12 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 3 | 3 | 5 | 6 | 5 | 5 | 10 | 9 | 12 | — |
Mar 2017
- 173
- 124
- Operating Profit
- 55
- OPM %
- 32
- Other Income
- 6
- Interest
- 3
- Depreciation
- 8
- 44
- Tax %
- 21
- Net Profit
- 35
- EPS
- 3
- Dividend Payout %
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2018
- 212
- 163
- Operating Profit
- 55
- OPM %
- 26
- Other Income
- 6
- Interest
- 3
- Depreciation
- 8
- 44
- Tax %
- 18
- Net Profit
- 36
- EPS
- 3
- Dividend Payout %
- 16
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2019
- 222
- 169
- Operating Profit
- 58
- OPM %
- 26
- Other Income
- 6
- Interest
- 3
- Depreciation
- 9
- 47
- Tax %
- 25
- Net Profit
- 35
- EPS
- 3
- Dividend Payout %
- 19
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2020
- 247
- 170
- Operating Profit
- 86
- OPM %
- 35
- Other Income
- 9
- Interest
- 1
- Depreciation
- 9
- 76
- Tax %
- 24
- Net Profit
- 58
- EPS
- 5
- Dividend Payout %
- 12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2021
- 283
- 183
- Operating Profit
- 108
- OPM %
- 38
- Other Income
- 7
- Interest
- 0
- Depreciation
- 9
- 98
- Tax %
- 28
- Net Profit
- 71
- EPS
- 6
- Dividend Payout %
- 14
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2022
- 273
- 200
- Operating Profit
- 82
- OPM %
- 30
- Other Income
- 9
- Interest
- 0
- Depreciation
- 10
- 72
- Tax %
- 24
- Net Profit
- 55
- EPS
- 5
- Dividend Payout %
- 21
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2023
- 312
- 236
- Operating Profit
- 85
- OPM %
- 27
- Other Income
- 10
- Interest
- 0
- Depreciation
- 10
- 74
- Tax %
- 25
- Net Profit
- 56
- EPS
- 5
- Dividend Payout %
- 20
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2024
- 365
- 260
- Operating Profit
- 164
- OPM %
- 45
- Other Income
- 59
- Interest
- 0
- Depreciation
- 11
- 134
- Tax %
- 19
- Net Profit
- 108
- EPS
- 10
- Dividend Payout %
- 53
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2025
- 351
- 280
- Operating Profit
- 132
- OPM %
- 38
- Other Income
- 61
- Interest
- 1
- Depreciation
- 11
- 121
- Tax %
- 15
- Net Profit
- 102
- EPS
- 9
- Dividend Payout %
- 57
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2026
- 453
- 343
- Operating Profit
- 174
- OPM %
- 38
- Other Income
- 64
- Interest
- 0
- Depreciation
- 12
- 158
- Tax %
- 16
- Net Profit
- 132
- EPS
- 12
- Dividend Payout %
- 45
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
TTM
- 444
- 336
- Operating Profit
- —
- OPM %
- —
- Other Income
- 12
- Interest
- 0
- Depreciation
- 12
- 106
- Tax %
- 24
- Net Profit
- 80
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 13%
- 5 Years:
- 10%
- 3 Years:
- 13%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 20%
- 5 Years:
- 13%
- 3 Years:
- 33%
STOCK PRICE CAGR
- 10 Years:
- 1%
- 5 Years:
- -4%
- 3 Years:
- -3%
- 1 Year:
- -4%
RETURN ON EQUITY
- 10 Years:
- 16%
- 5 Years:
- 16%
- 3 Years:
- 19%
- Last Year:
- 20%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| 233 | 264 | 294 | 345 | 410 | 457 | 503 | 555 | 602 | 678 | |
| 21 | 32 | 17 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 8 | 21 | 16 | 14 | 23 | 20 | 18 | 22 | 25 | 51 |
| 33 | 33 | 28 | 34 | 34 | 30 | 32 | 34 | 39 | 52 | |
| Total Liabilities | 318 | 373 | 376 | 423 | 490 | 530 | 576 | 633 | 689 | 804 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 98 | 98 | 97 | 127 | 132 | 132 | 143 | 142 | 156 | 151 | |
| Capital Work in Progress | 1 | 2 | 1 | 5 | 2 | 3 | 6 | 16 | 21 | 49 |
| 103 | 120 | 120 | 121 | 184 | 189 | 201 | 256 | 290 | 345 | |
| 51 | 55 | 59 | 60 | 63 | 80 | 77 | 97 | 101 | 117 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 75 | 78 | 94 | |
| Cash & Bank | 1 | 0 | 1 | 3 | 2 | 18 | 25 | 2 | 6 | 2 |
| 63 | 97 | 98 | 108 | 106 | 107 | 124 | 44 | 36 | 46 | |
| Total Assets | 318 | 373 | 376 | 423 | 490 | 530 | 576 | 633 | 689 | 804 |
| Total Debt | 38 | 45 | 19 | 10 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net Working Capital | 52 | 34 | 57 | 90 | 119 | 140 | 153 | 208 | 188 | 238 |
| Contingent Liabilities | 25 | 28 | 29 | 14 | 11 | 5 | 5 | 5 | 8 | 6 |
| Book Value per Share | 114.18 | 25.64 | 28.30 | 32.85 | 38.74 | 42.91 | 46.98 | 51.64 | 55.81 | 62.58 |
| Face Value | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Total Debt | 38 | 45 | 19 | 10 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net Working Capital | 52 | 34 | 57 | 90 | 119 | 140 | 153 | 208 | 188 | 238 |
| Contingent Liabilities | 25 | 28 | 29 | 14 | 11 | 5 | 5 | 5 | 8 | 6 |
| Book Value per Share | 114.18 | 25.64 | 28.30 | 32.85 | 38.74 | 42.91 | 46.98 | 51.64 | 55.81 | 62.58 |
| Face Value | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Mar 2017
- Equity Capital
- 22
- 233
- 21
- Trade Payables
- 8
- 33
- Total Liabilities
- 318
- 98
- Capital Work in Progress
- 1
- 103
- 51
- 0
- Cash & Bank
- 1
- 63
- Total Assets
- 318
- Total Debt
- 38
- Net Working Capital
- 52
- Contingent Liabilities
- 25
- Book Value per Share
- 114.18
- Face Value
- 10.00
- Total Debt
- 38
- Net Working Capital
- 52
- Contingent Liabilities
- 25
- Book Value per Share
- 114.18
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 22
- 264
- 32
- Trade Payables
- 21
- 33
- Total Liabilities
- 373
- 98
- Capital Work in Progress
- 2
- 120
- 55
- 0
- Cash & Bank
- 0
- 97
- Total Assets
- 373
- Total Debt
- 45
- Net Working Capital
- 34
- Contingent Liabilities
- 28
- Book Value per Share
- 25.64
- Face Value
- 2.00
- Total Debt
- 45
- Net Working Capital
- 34
- Contingent Liabilities
- 28
- Book Value per Share
- 25.64
- Face Value
- 2.00
Mar 2019
- Equity Capital
- 22
- 294
- 17
- Trade Payables
- 16
- 28
- Total Liabilities
- 376
- 97
- Capital Work in Progress
- 1
- 120
- 59
- 0
- Cash & Bank
- 1
- 98
- Total Assets
- 376
- Total Debt
- 19
- Net Working Capital
- 57
- Contingent Liabilities
- 29
- Book Value per Share
- 28.30
- Face Value
- 2.00
- Total Debt
- 19
- Net Working Capital
- 57
- Contingent Liabilities
- 29
- Book Value per Share
- 28.30
- Face Value
- 2.00
Mar 2020
- Equity Capital
- 22
- 345
- 8
- Trade Payables
- 14
- 34
- Total Liabilities
- 423
- 127
- Capital Work in Progress
- 5
- 121
- 60
- 0
- Cash & Bank
- 3
- 108
- Total Assets
- 423
- Total Debt
- 10
- Net Working Capital
- 90
- Contingent Liabilities
- 14
- Book Value per Share
- 32.85
- Face Value
- 2.00
- Total Debt
- 10
- Net Working Capital
- 90
- Contingent Liabilities
- 14
- Book Value per Share
- 32.85
- Face Value
- 2.00
Mar 2021
- Equity Capital
- 22
- 410
- 0
- Trade Payables
- 23
- 34
- Total Liabilities
- 490
- 132
- Capital Work in Progress
- 2
- 184
- 63
- 0
- Cash & Bank
- 2
- 106
- Total Assets
- 490
- Total Debt
- 1
- Net Working Capital
- 119
- Contingent Liabilities
- 11
- Book Value per Share
- 38.74
- Face Value
- 2.00
- Total Debt
- 1
- Net Working Capital
- 119
- Contingent Liabilities
- 11
- Book Value per Share
- 38.74
- Face Value
- 2.00
Mar 2022
- Equity Capital
- 22
- 457
- 0
- Trade Payables
- 20
- 30
- Total Liabilities
- 530
- 132
- Capital Work in Progress
- 3
- 189
- 80
- 0
- Cash & Bank
- 18
- 107
- Total Assets
- 530
- Total Debt
- 0
- Net Working Capital
- 140
- Contingent Liabilities
- 5
- Book Value per Share
- 42.91
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 140
- Contingent Liabilities
- 5
- Book Value per Share
- 42.91
- Face Value
- 2.00
Mar 2023
- Equity Capital
- 22
- 503
- 0
- Trade Payables
- 18
- 32
- Total Liabilities
- 576
- 143
- Capital Work in Progress
- 6
- 201
- 77
- 0
- Cash & Bank
- 25
- 124
- Total Assets
- 576
- Total Debt
- 0
- Net Working Capital
- 153
- Contingent Liabilities
- 5
- Book Value per Share
- 46.98
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 153
- Contingent Liabilities
- 5
- Book Value per Share
- 46.98
- Face Value
- 2.00
Mar 2024
- Equity Capital
- 22
- 555
- 0
- Trade Payables
- 22
- 34
- Total Liabilities
- 633
- 142
- Capital Work in Progress
- 16
- 256
- 97
- 75
- Cash & Bank
- 2
- 44
- Total Assets
- 633
- Total Debt
- 0
- Net Working Capital
- 208
- Contingent Liabilities
- 5
- Book Value per Share
- 51.64
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 208
- Contingent Liabilities
- 5
- Book Value per Share
- 51.64
- Face Value
- 2.00
Mar 2025
- Equity Capital
- 22
- 602
- 0
- Trade Payables
- 25
- 39
- Total Liabilities
- 689
- 156
- Capital Work in Progress
- 21
- 290
- 101
- 78
- Cash & Bank
- 6
- 36
- Total Assets
- 689
- Total Debt
- 0
- Net Working Capital
- 188
- Contingent Liabilities
- 8
- Book Value per Share
- 55.81
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 188
- Contingent Liabilities
- 8
- Book Value per Share
- 55.81
- Face Value
- 2.00
Mar 2026
- Equity Capital
- 22
- 678
- 0
- Trade Payables
- 51
- 52
- Total Liabilities
- 804
- 151
- Capital Work in Progress
- 49
- 345
- 117
- 94
- Cash & Bank
- 2
- 46
- Total Assets
- 804
- Total Debt
- 0
- Net Working Capital
- 238
- Contingent Liabilities
- 6
- Book Value per Share
- 62.58
- Face Value
- 2.00
- Total Debt
- 0
- Net Working Capital
- 238
- Contingent Liabilities
- 6
- Book Value per Share
- 62.58
- Face Value
- 2.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | 23 | 35 | 46 | 84 | 37 | 50 | 52 | 63 | 89 | |
| Cash from Investing | -55 | -22 | -2 | -25 | -70 | -14 | -42 | -3 | -2 | -34 |
| Cash from Financing | 34 | -1 | -33 | -19 | -15 | -11 | -12 | -57 | -58 | -58 |
| -0 | -0 | -0 | 2 | -1 | 12 | -4 | -8 | 4 | -4 | |
| Free Cash Flow | 21 | 14 | 29 | 4 | 73 | 26 | 28 | 32 | 34 | 55 |
| OCF / Net Profit | 0.61 | 0.63 | 1.00 | 0.79 | 1.19 | 0.68 | 0.91 | 0.48 | 0.62 | 0.67 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 141 | 147 | 160 | 163 | 193 | 175 |
| OCF / Net Profit | 0.61 | 0.63 | 1.00 | 0.79 | 1.19 | 0.68 | 0.91 | 0.48 | 0.62 | 0.67 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 141 | 147 | 160 | 163 | 193 | 175 |
Mar 2017
- 21
- Cash from Investing
- -55
- Cash from Financing
- 34
- -0
- Free Cash Flow
- 21
- OCF / Net Profit
- 0.61
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.61
- Cumulative 5-Year FCF
- 0
Mar 2018
- 23
- Cash from Investing
- -22
- Cash from Financing
- -1
- -0
- Free Cash Flow
- 14
- OCF / Net Profit
- 0.63
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.63
- Cumulative 5-Year FCF
- 0
Mar 2019
- 35
- Cash from Investing
- -2
- Cash from Financing
- -33
- -0
- Free Cash Flow
- 29
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- 0
Mar 2020
- 46
- Cash from Investing
- -25
- Cash from Financing
- -19
- 2
- Free Cash Flow
- 4
- OCF / Net Profit
- 0.79
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.79
- Cumulative 5-Year FCF
- 0
Mar 2021
- 84
- Cash from Investing
- -70
- Cash from Financing
- -15
- -1
- Free Cash Flow
- 73
- OCF / Net Profit
- 1.19
- Cumulative 5-Year FCF
- 141
- OCF / Net Profit
- 1.19
- Cumulative 5-Year FCF
- 141
Mar 2022
- 37
- Cash from Investing
- -14
- Cash from Financing
- -11
- 12
- Free Cash Flow
- 26
- OCF / Net Profit
- 0.68
- Cumulative 5-Year FCF
- 147
- OCF / Net Profit
- 0.68
- Cumulative 5-Year FCF
- 147
Mar 2023
- 50
- Cash from Investing
- -42
- Cash from Financing
- -12
- -4
- Free Cash Flow
- 28
- OCF / Net Profit
- 0.91
- Cumulative 5-Year FCF
- 160
- OCF / Net Profit
- 0.91
- Cumulative 5-Year FCF
- 160
Mar 2024
- 52
- Cash from Investing
- -3
- Cash from Financing
- -57
- -8
- Free Cash Flow
- 32
- OCF / Net Profit
- 0.48
- Cumulative 5-Year FCF
- 163
- OCF / Net Profit
- 0.48
- Cumulative 5-Year FCF
- 163
Mar 2025
- 63
- Cash from Investing
- -2
- Cash from Financing
- -58
- 4
- Free Cash Flow
- 34
- OCF / Net Profit
- 0.62
- Cumulative 5-Year FCF
- 193
- OCF / Net Profit
- 0.62
- Cumulative 5-Year FCF
- 193
Mar 2026
- 89
- Cash from Investing
- -34
- Cash from Financing
- -58
- -4
- Free Cash Flow
- 55
- OCF / Net Profit
- 0.67
- Cumulative 5-Year FCF
- 175
- OCF / Net Profit
- 0.67
- Cumulative 5-Year FCF
- 175
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 15.48 | 3.22 | 3.16 | 5.19 | 6.36 | 4.88 | 4.97 | 9.67 | 9.15 | 11.78 |
| Book Value (₹) | 114.18 | 25.64 | 28.30 | 32.85 | 38.74 | 42.91 | 46.98 | 51.64 | 55.81 | 62.58 |
| Dividend per Share (₹) | 2.00 | 0.50 | 0.60 | 0.60 | 0.90 | 1.00 | 1.00 | 5.10 | 5.20 | 5.35 |
| Cash EPS (₹) | 3.84 | 3.92 | 3.92 | 5.98 | 7.16 | 5.73 | 5.89 | 10.64 | 10.17 | 12.86 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 29.88% | 25.55% | 26.33% | 34.73% | 37.42% | 29.90% | 27.18% | 28.74% | 20.19% | 24.18% |
| Net Margin % | 18.81% | 16.66% | 15.86% | 23.42% | 24.68% | 19.90% | 17.78% | 29.52% | 29.15% | 29.02% |
| ROE % | 16.11% | 13.26% | 11.70% | 16.98% | 17.76% | 11.95% | 11.05% | 19.61% | 17.04% | 19.90% |
| ROCE % | 18.06% | 15.07% | 14.85% | 21.45% | 24.16% | 15.78% | 14.83% | 24.30% | 20.01% | 23.63% |
| 11.96% | 10.39% | 9.41% | 14.51% | 15.57% | 10.70% | 10.05% | 17.89% | 15.50% | 17.67% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 53 | 59 | 63 | 66 | 68 | 69 | 68 | 71 | 80 | 69 |
| Inventory Days | 98 | 90 | 93 | 87 | 78 | 96 | 92 | 87 | 103 | 88 |
| Payable Days | 51 | 63 | 78 | 60 | 69 | 79 | 57 | 55 | 60 | 75 |
| 100 | 85 | 78 | 93 | 77 | 86 | 102 | 102 | 123 | 82 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.15x | 0.16x | 0.06x | 0.03x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Interest Coverage (x) | 15.87x | 14.01x | 18.34x | 59.71x | 414.56x | 265.97x | 226.08x | 347.23x | 239.20x | 316.98x |
| 2.19x | 1.49x | 2.27x | 3.52x | 3.90x | 4.87x | 5.14x | 6.21x | 5.25x | 4.06x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 24.08% | 22.83% | 4.73% | 11.37% | 14.60% | -3.77% | 14.20% | 17.31% | -3.85% | 28.84% |
| Operating Profit Growth % | 47.45% | 0.20% | 6.30% | 46.96% | 25.26% | -23.93% | 3.65% | 93.45% | -19.36% | 31.47% |
| Net Profit Growth % | 65.45% | 3.82% | -1.83% | 64.49% | 22.53% | -23.24% | 1.86% | 94.72% | -5.27% | 28.69% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 94.72% | -5.32% | 28.64% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 35.94x | 30.47x | 21.69x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 6.73x | 5.00x | 4.08x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.47% | 1.86% | 2.09% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 23.65x | 23.52x | 16.40x |
Mar 2017
- EPS (₹)
- 15.48
- Book Value (₹)
- 114.18
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 3.84
- Operating Margin %
- 29.88%
- Net Margin %
- 18.81%
- ROE %
- 16.11%
- ROCE %
- 18.06%
- 11.96%
- Debtor Days
- 53
- Inventory Days
- 98
- Payable Days
- 51
- 100
- Debt to Equity (x)
- 0.15x
- Interest Coverage (x)
- 15.87x
- 2.19x
- Revenue Growth %
- 24.08%
- Operating Profit Growth %
- 47.45%
- Net Profit Growth %
- 65.45%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 3.22
- Book Value (₹)
- 25.64
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 3.92
- Operating Margin %
- 25.55%
- Net Margin %
- 16.66%
- ROE %
- 13.26%
- ROCE %
- 15.07%
- 10.39%
- Debtor Days
- 59
- Inventory Days
- 90
- Payable Days
- 63
- 85
- Debt to Equity (x)
- 0.16x
- Interest Coverage (x)
- 14.01x
- 1.49x
- Revenue Growth %
- 22.83%
- Operating Profit Growth %
- 0.20%
- Net Profit Growth %
- 3.82%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 3.16
- Book Value (₹)
- 28.30
- Dividend per Share (₹)
- 0.60
- Cash EPS (₹)
- 3.92
- Operating Margin %
- 26.33%
- Net Margin %
- 15.86%
- ROE %
- 11.70%
- ROCE %
- 14.85%
- 9.41%
- Debtor Days
- 63
- Inventory Days
- 93
- Payable Days
- 78
- 78
- Debt to Equity (x)
- 0.06x
- Interest Coverage (x)
- 18.34x
- 2.27x
- Revenue Growth %
- 4.73%
- Operating Profit Growth %
- 6.30%
- Net Profit Growth %
- -1.83%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 5.19
- Book Value (₹)
- 32.85
- Dividend per Share (₹)
- 0.60
- Cash EPS (₹)
- 5.98
- Operating Margin %
- 34.73%
- Net Margin %
- 23.42%
- ROE %
- 16.98%
- ROCE %
- 21.45%
- 14.51%
- Debtor Days
- 66
- Inventory Days
- 87
- Payable Days
- 60
- 93
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 59.71x
- 3.52x
- Revenue Growth %
- 11.37%
- Operating Profit Growth %
- 46.96%
- Net Profit Growth %
- 64.49%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 6.36
- Book Value (₹)
- 38.74
- Dividend per Share (₹)
- 0.90
- Cash EPS (₹)
- 7.16
- Operating Margin %
- 37.42%
- Net Margin %
- 24.68%
- ROE %
- 17.76%
- ROCE %
- 24.16%
- 15.57%
- Debtor Days
- 68
- Inventory Days
- 78
- Payable Days
- 69
- 77
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 414.56x
- 3.90x
- Revenue Growth %
- 14.60%
- Operating Profit Growth %
- 25.26%
- Net Profit Growth %
- 22.53%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 4.88
- Book Value (₹)
- 42.91
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 5.73
- Operating Margin %
- 29.90%
- Net Margin %
- 19.90%
- ROE %
- 11.95%
- ROCE %
- 15.78%
- 10.70%
- Debtor Days
- 69
- Inventory Days
- 96
- Payable Days
- 79
- 86
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 265.97x
- 4.87x
- Revenue Growth %
- -3.77%
- Operating Profit Growth %
- -23.93%
- Net Profit Growth %
- -23.24%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 4.97
- Book Value (₹)
- 46.98
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 5.89
- Operating Margin %
- 27.18%
- Net Margin %
- 17.78%
- ROE %
- 11.05%
- ROCE %
- 14.83%
- 10.05%
- Debtor Days
- 68
- Inventory Days
- 92
- Payable Days
- 57
- 102
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 226.08x
- 5.14x
- Revenue Growth %
- 14.20%
- Operating Profit Growth %
- 3.65%
- Net Profit Growth %
- 1.86%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 9.67
- Book Value (₹)
- 51.64
- Dividend per Share (₹)
- 5.10
- Cash EPS (₹)
- 10.64
- Operating Margin %
- 28.74%
- Net Margin %
- 29.52%
- ROE %
- 19.61%
- ROCE %
- 24.30%
- 17.89%
- Debtor Days
- 71
- Inventory Days
- 87
- Payable Days
- 55
- 102
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 347.23x
- 6.21x
- Revenue Growth %
- 17.31%
- Operating Profit Growth %
- 93.45%
- Net Profit Growth %
- 94.72%
- 94.72%
- P/E (x)
- 35.94x
- P/B (x)
- 6.73x
- Dividend Yield %
- 1.47%
- 23.65x
Mar 2025
- EPS (₹)
- 9.15
- Book Value (₹)
- 55.81
- Dividend per Share (₹)
- 5.20
- Cash EPS (₹)
- 10.17
- Operating Margin %
- 20.19%
- Net Margin %
- 29.15%
- ROE %
- 17.04%
- ROCE %
- 20.01%
- 15.50%
- Debtor Days
- 80
- Inventory Days
- 103
- Payable Days
- 60
- 123
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 239.20x
- 5.25x
- Revenue Growth %
- -3.85%
- Operating Profit Growth %
- -19.36%
- Net Profit Growth %
- -5.27%
- -5.32%
- P/E (x)
- 30.47x
- P/B (x)
- 5.00x
- Dividend Yield %
- 1.86%
- 23.52x
Mar 2026
- EPS (₹)
- 11.78
- Book Value (₹)
- 62.58
- Dividend per Share (₹)
- 5.35
- Cash EPS (₹)
- 12.86
- Operating Margin %
- 24.18%
- Net Margin %
- 29.02%
- ROE %
- 19.90%
- ROCE %
- 23.63%
- 17.67%
- Debtor Days
- 69
- Inventory Days
- 88
- Payable Days
- 75
- 82
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 316.98x
- 4.06x
- Revenue Growth %
- 28.84%
- Operating Profit Growth %
- 31.47%
- Net Profit Growth %
- 28.69%
- 28.64%
- P/E (x)
- 21.69x
- P/B (x)
- 4.08x
- Dividend Yield %
- 2.09%
- 16.40x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-18 - Advanced Enzyme Technologies Limited has informed the Exchange about Transcript
- General Updates
2026-08-13 - Advanced Enzyme Technologies Limited has informed the Exchange about General Updates
Annual Reports
Credit Ratings
- Credit Rating
2026-05-06 - Advanced Enzyme Technologies Limited has informed the Exchange about Credit Rating
Concalls
Aug 2026
May 2026
Feb 2026